atamestane has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, AM; Goss, PE; Hu, H; Qi, S | 1 |
| Brodie, A; Goloubeva, O; Macedo, L; Sabnis, GJ; Schayowitz, A; Zhu, Y | 1 |
| el Etreby, MF; Habenicht, UF | 1 |
| el Etreby, MF; Habenicht, UF; Neumann, F; Schwarz, K | 1 |
1 review(s) available for atamestane and Disease Models, Animal
| Article | Year |
|---|---|
The function and the role of aromatase inhibitors in the treatment of BPH.
Topics: Androgens; Androstenedione; Animals; Aromatase Inhibitors; Clinical Trials as Topic; Disease Models, Animal; Estrogens; Flutamide; Humans; Macaca fascicularis; Male; Prostate; Prostatic Hyperplasia | 1994 |
3 other study(ies) available for atamestane and Disease Models, Animal
| Article | Year |
|---|---|
The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model.
Topics: Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Disease Models, Animal; Female; Humans; Letrozole; Lipids; Models, Chemical; Nitriles; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Toremifene; Triazoles; Uterus | 2007 |
Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase model.
Topics: Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, SCID; Prognosis; Toremifene; Transfection; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Disease Models, Animal; Estradiol; Macaca fascicularis; Male; Organ Size; Prostate; Prostatic Hyperplasia | 1987 |